Trials / Completed
CompletedNCT01755676
Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults
A Prospective Study, Parallel, Double-blind, Multicenter for Evaluation of Efficacy of Orlistat 60 mg as Adjuvant Treatment of Obesity in Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 638 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate efficacy of orlistat 60 mg as adjuvant treatment of Obesity in adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Orlistat 60 mg | 1 tablet 3 times a day |
| OTHER | Placebo | 1 tablet 3 times a day |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-21
- First posted
- 2012-12-24
- Last updated
- 2020-04-07
Locations
5 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01755676. Inclusion in this directory is not an endorsement.